Main |
Browse Volumes |
Forthcoming Volumes |
Annals PrePrints |
Annals Extra |
E-mail Alerts |
Subscriptions & Orders |
New Proposals |
Author Guidelines |
About Annals |
Help |
 |
|
 |
|
|
|
|
NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES
Volume 840 published May 1998
Editors: |  | Samuel M. McCann
Esther M. Sternberg
James M. Lipton
George P. Chrousos
Philip W. Gold
Craig C. Smith
|
Index of Authors
|
|
Contents
 |
New Perspectives in Neuroimmunomodulation |
 |
Neuroimmunomodulation: Molecular Aspects, Integrative Systems, and Clinical Advances: New Perspectives in Neuroimmunomodulation |
 |
Part I. Molecular Aspects of Neuroimmunomodulation: Cytokines and the Central Nervous System |
 |
Part I. Molecular Aspects of Neuroimmunomodulation: Cytokines and Endocrine Function |
 |
Part I. Molecular Aspects of Neuroimmunomodulation: Sex Hormones, NOS, and Immunity |
 |
Part II. Integrative Aspects of Neuroimmunomodulation: Nervous System Inputs to Inflammation |
 |
Part II. Integrative Aspects of Neuroimmunomodulation: Apoptosis, Glucocorticoids, and Thymic Immunity |
 |
Part II. Integrative Aspects of Neuroimmunomodulation: Melatonin, MSH, Opiates, and Immune Function |
 |
Part II. Integrative Aspects of Neuroimmunomodulation: Hypothalamic-Pituitary-Adrenal Axis and Glucocorticoids |
 |
Part II. Integrative Aspects of Neuroimmunomodulation: Thymus-Neuroendocrine Interactions |
 |
Part II. Integrative Aspects of Neuroimmunomodulation: Growth Hormone, Prolactin, and POMC |
 |
Part II. Integrative Aspects of Neuroimmunomodulation: VIP, Substance P, and Calcitonin |
 |
Part III. Disturbances in Neuroendocrine-Immune Interactions: Clinical, Behavioral, and Therapeutic Implications |
 |
Part III. Disturbances in Neuroendocrine-Immune Interactions: Clinical, Behavioral, and Therapeutic Implications: Behavior and the Immune System: Animal Models |
 |
Part III. Disturbances in Neuroendocrine-Immune Interactions: Clinical, Behavioral, and Therapeutic Implications: Human Behavior and Immune Responses |
 |
Part III. Disturbances in Neuroendocrine-Immune Interactions: Clinical, Behavioral, and Therapeutic Implications: Inflammatory Diseases: Human and Animal Models |
 |
Part III. Disturbances in Neuroendocrine-Immune Interactions: Clinical, Behavioral, and Therapeutic Implications: Stress, Neuroendocrine Responses, and Allergic Disease |
 |
Part III. Disturbances in Neuroendocrine-Immune Interactions: Clinical, Behavioral, and Therapeutic Implications: Stress, Neuroendocrine Responses, and Infectious Diseases |
|
|
|
|